These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 28451991

  • 1. [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.
    Weng CC, Huang SL, Chen ZA, Lin KJ, Hsiao IT, Yen TC, Kung MP, Wey SP, Hsu CH.
    Ann Nucl Med; 2017 Aug; 31(7):506-513. PubMed ID: 28451991
    [Abstract] [Full Text] [Related]

  • 2. PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data.
    Tang J, Xu Y, Liu C, Fang Y, Cao S, Zhao C, Huang H, Zou M, Chen Z.
    Nucl Med Biol; 2020 Aug; 90-91():1-9. PubMed ID: 32861175
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC, Chen ZA, Chao KT, Ee TW, Lin KJ, Chan MH, Hsiao IT, Yen TC, Kung MP, Hsu CH, Wey SP.
    PLoS One; 2017 Aug; 12(3):e0173503. PubMed ID: 28257461
    [Abstract] [Full Text] [Related]

  • 4. Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent.
    Liu F, Choi SR, Zha Z, Ploessl K, Zhu L, Kung HF.
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y, Tang J, Liu C, Zhao C, Cao S, Yu H, Chen Z, Xie M.
    Nucl Med Biol; 2021 Feb; 96-97():9-18. PubMed ID: 33647803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ.
    Zhao C, Liu C, Tang J, Xu Y, Xie M, Chen Z.
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [Abstract] [Full Text] [Related]

  • 12. Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.
    Zhu L, Qiao H, Lieberman BP, Wu J, Liu Y, Pan Z, Ploessl K, Choi SR, Chan P, Kung HF.
    Nucl Med Biol; 2012 Oct; 39(7):897-904. PubMed ID: 22749185
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of 18F-FP-DTBZ in baboons.
    Naganawa M, Lin SF, Lim K, Labaree D, Ropchan J, Harris P, Huang Y, Ichise M, Carson RE, Cline GW.
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [Abstract] [Full Text] [Related]

  • 14. Quantitative study of 18F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis.
    Jung Lung H, Weng YH, Wen MC, Hsiao IT, Lin KJ.
    Sci Rep; 2018 Oct 30; 8(1):16027. PubMed ID: 30375444
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ.
    JAMA Neurol; 2014 Jun 30; 71(6):758-66. PubMed ID: 24756323
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C, Peñuelas I, Obeso JA.
    Neurobiol Dis; 2015 May 30; 77():165-72. PubMed ID: 25681534
    [Abstract] [Full Text] [Related]

  • 19. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF.
    J Nucl Med; 2008 Jul 30; 49(7):1171-6. PubMed ID: 18552132
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
    Chao KT, Tsao HH, Weng YH, Hsiao IT, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lin KJ.
    Synapse; 2012 Sep 30; 66(9):823-31. PubMed ID: 22623146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.